Interesting read from Goldman Sachs about the Chinese consumer staples market - the growing demand for better nutrition (Adult & Baby).
This report further supports the strength in fundamentals for A2m to grow exponentially in the coming years.
Not sure if I agree with their uplift forecasts for BAL (due to it's current non CFDA status) but I think the A2M forecast is more than reasonable over the coming year!
Hopefully their forecast will be the reverse of their respective forecasts in the end result "
Keep the faith!
"A2m - One of the best 3 to 5 year growth stocks .....if you own don't sell - if you don't own buy some...."
GLTA to all LT SH's & DYOR
Full Report
Chart Update, page-1587
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.28 |
Change
0.090(1.73%) |
Mkt cap ! $3.822B | |||
| Open | High | Low | Value | Volume |
| $5.23 | $5.29 | $5.14 | $18.87M | 3.614M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12652 | $5.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.29 | 3513 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |